Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
11/1999
11/04/1999WO1999055367A1 INTERNALIZING ErbB2 ANTIBODIES
11/04/1999WO1999042597A9 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
11/04/1999WO1999034004A3 Metastatic breast and colon cancer regulated genes
11/04/1999CA2330560A1 Methods for transducing fusion molecules
11/04/1999CA2327352A1 Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein
11/04/1999CA2326377A1 Internalizing erbb2 antibodies
11/04/1999CA2326376A1 Polyepitope carrier protein
11/04/1999CA2325055A1 Vaccines containing recombinant pilin against neisseria gonorrhoeae or neisseria meningitidis
11/03/1999EP0953639A1 FAPalpha-specific antibody with improved producibility
11/03/1999EP0953153A1 Novel method of diagnosing and treating gliomas
11/03/1999EP0952981A1 Method for producing a correctly folded, biological active recombinant protein
11/03/1999EP0371998B2 Modular assembly of antibody genes, antibodies prepared thereby and use
11/02/1999US5977438 Production of peptides in plants as viral coat protein fusions
11/02/1999US5977315 Murine anti-idiotype antibody 3H1
11/02/1999US5977314 Catalytic antibodies against cocaine
11/02/1999US5976861 Proteins for the isolation of antibodies.
11/02/1999US5976841 Proteins having fibrinolytic and coagulation--inhibiting properties
11/02/1999US5976796 The gene product alone can be sufficient to allow detection of living cells under the light microscope.
11/02/1999US5976544 Polypeptides and vaccines for Bordetellapertussis and method of use
11/02/1999CA2053911C Recombinant antibody-toxin fusion protein
10/1999
10/28/1999WO1999054732A1 IλB AND ENHANCED GREEN FLUORESCENT FUSION PROTEIN
10/28/1999WO1999054468A1 Soluble protein ztmpo-1
10/28/1999WO1999054467A1 Sh2 domain-containing peptides
10/28/1999WO1999054457A1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates
10/28/1999WO1999054440A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF
10/28/1999WO1999054359A1 Matrix binding factor
10/28/1999WO1999054348A1 Rapidly degrading gfp-fusion proteins and methods of use
10/28/1999WO1999053958A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor
10/28/1999CA2658218A1 Improved immunodiagnostic assays using reducing agents
10/28/1999CA2328888A1 Rapidly degrading gfp-fusion proteins and methods of use
10/28/1999CA2328463A1 Matrix binding factor
10/28/1999CA2328081A1 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor
10/28/1999CA2326670A1 Ikb and enhanced green fluorescent fusion protein
10/28/1999CA2325822A1 Soluble protein ztmpo-1
10/28/1999CA2324297A1 Sh2 domain-containing peptides
10/27/1999EP0951550A1 Mammalian cytokine related to il10
10/27/1999EP0951549A1 Mammalian chemokines
10/27/1999EP0951295A1 Methods and compositions useful for inhibition of angiogenesis
10/27/1999EP0951272A1 An oral care product comprising a mutan binding domain
10/27/1999EP0830601B1 Use of a phycobiliprotein-linker peptide complex as a fluorescent tracer
10/27/1999CN1233288A GnRH-leukotoxin chimeras
10/26/1999US5973132 Expression of dna coding for house dust mite allergens.
10/26/1999US5973116 Compounds for targeting
10/26/1999US5972901 Making a composition for delivering an oligonucleotide to a mammalian cell by providing a peptide target binding moiety being capable of binding to a serpin enzyme complex receptor, polylysine, an oligonucleotide vector; conjugating, coupling
10/26/1999US5972900 Conjugating target binding moiety consisting of an antibody or fragment which binds to secretory component of polymeric immunoglobulin receptor on surface of epithelium cell, nucleic acid binder, expression vector, compacting, administering
10/26/1999US5972896 Antiangiogenic peptides and methods for inhibiting angiogenesis
10/26/1999US5972659 Introducing into e. coli a heterologous plasmid expression vector coding for the tobacco mosaic virus protein coat and a pathogen's epitope, separating fusion protein and lowering ph to form a self-aggregated protein and hapten for vaccines
10/26/1999US5972352 Cloning of mite allergens
10/26/1999US5972338 ?tie? or ?tie? are acronyms, which stand for ?tyrosine kinase containing ig and egf homology domains?; present invention concerns novel human tie ligand homologues with powerful effects on vasculature; antitumor agents
10/26/1999US5972337 46 kilodalton human milk fat globule (HMFG) antigen, fragments and fusion protein
10/26/1999US5972336 Urease-based vaccine against helicobacter infection
10/26/1999CA2057536C Cloning and expression of borrelia lipoproteins
10/21/1999WO1999053062A2 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof
10/21/1999WO1999053058A1 Vertebrate patched-2 protein
10/21/1999WO1999053053A1 Gene coding for heliomicine and use thereof
10/21/1999WO1999052562A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor
10/21/1999WO1999052552A1 T cell inhibitory receptor compositions and uses thereof
10/21/1999WO1999046379A3 Human receptor proteins; related reagents and methods
10/21/1999WO1999045119A3 Production of mycobacterial polypeptides by lactic acid bacteria
10/21/1999WO1999042118A8 Compounds and methods for diagnosis of tuberculosis
10/21/1999WO1999036553A3 Regulation of biological events using multimeric chimeric proteins
10/21/1999CA2328725A1 T cell inhibitory receptor compositions and uses thereof
10/21/1999CA2325658A1 Gene coding for heliomicine and use thereof
10/20/1999EP0950710A2 Cells expressing a chimera receptor and their uses
10/20/1999CN1232501A Modified TIE-2 -receptor ligands
10/20/1999CN1232469A RET ligand (RetL) for stimulating neural and renal growth
10/19/1999US5969126 GNRH-leukotoxin chimeras
10/19/1999US5969110 Antibodies which are immunoreactive with a human tyrosine kinase ligand protein
10/19/1999US5969109 Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
10/19/1999US5969108 Methods for producing members of specific binding pairs
10/19/1999US5968776 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
10/19/1999US5968750 Humanized green fluorescent protein genes and methods
10/19/1999US5968734 Dna sequences that migrate to new genetic positions and the fusion products; diagnosis of carcinomas, melanomas, and sarcomas suchas ewing's sarcoma
10/19/1999CA1340790C Method of diagnosis and severity-assessment of human pancreatic disease
10/14/1999WO1999051748A2 Fusion proteins of mycobacterium tuberculosis antigens and their uses
10/14/1999WO1999051741A2 Lyst protein complexes and lyst interacting proteins
10/14/1999WO1999051737A1 Highly active forms of interferon regulatory factor proteins
10/14/1999WO1999051643A1 Mutagenized il13-based chimeric molecules
10/14/1999WO1999051642A1 Antibody variants and fragments thereof
10/14/1999WO1999051638A1 DUAL Avb3 AND METASTASIS-ASSOCIATED RECEPTOR LIGANDS
10/14/1999WO1999051632A1 Circularly permuted biotin binding proteins
10/14/1999WO1999051258A1 USE OF ANTI-gp39 ANTIBODIES FOR TREATMENT AND/OR REVERSAL OF LUPUS AND ASSOCIATED KIDNEY DISEASE
10/14/1999WO1999040188A3 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccinations
10/14/1999WO1999028462A3 Polypeptides and nucleic acids encoding the same
10/14/1999CA2326598A1 Fusion proteins of mycobacterium tuberculosis antigens and their uses
10/14/1999CA2325562A1 Lyst protein complexes and lyst interacting proteins
10/14/1999CA2325342A1 Dual avb3 and metastasis-associated receptor ligands
10/14/1999CA2325341A1 Mutagenized il13-based chimeric molecules
10/14/1999CA2324205A1 Circularly permuted biotin binding proteins
10/13/1999EP0949332A2 HSSCRG1 polypeptides
10/13/1999EP0948631A1 Over-expression of proteins
10/13/1999EP0948623A2 Isolated mammalian monocyte cell genes; related reagents
10/13/1999EP0948538A1 Analysis and separation of platelet-derived growth factor proteins
10/13/1999EP0948531A1 Secreted human proteins
10/13/1999EP0948530A2 Mammalian cell surface antigens; related reagents
10/13/1999EP0948520A1 Tissue specific expression of retinoblastoma protein
10/13/1999EP0948360A1 Novel lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use
10/13/1999EP0777678B1 Pna combinatorial libraries and improved methods of synthesis
10/13/1999EP0770088A4 Novel cytokine designated lerk-5
10/13/1999EP0564592B1 Liver enriched transcription factor
1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 295